Sirolimus treatment of left ventricular hypertrophy: who, and when?

dc.contributor.author	Crespo-Leiro, María Generosa
dc.contributor.author	Hermida-Prieto, Manuel
dc.date.accessioned	2018-09-05T09:58:08Z
dc.date.available	2018-09-05T09:58:08Z
dc.date.issued	2008-10-19
dc.identifier.citation	Crespo-Leiro MG, Hermida-Prieto M. Sirolimus treatment of left ventricular hypertrophy: who, and when?. Eur Heart J. 2008;29(22):2703-2704	es_ES
dc.identifier.issn	0195-668X
dc.identifier.uri	http://hdl.handle.net/2183/20991
dc.description	This editorial refers to "Sirolimus affects ardiomyocytes to reduce left ventricular mass in hear transplant recipients" by S.S. Kushwaha et al., on page 2742	es_ES
dc.language.iso	eng	es_ES
dc.publisher	Oxford	es_ES
dc.relation.uri	https://doi.org/10.1093/eurheartj/ehn470	es_ES
dc.rights	This is a pre-copyedited, author-produced version of an article accepted for publication in "European Heart Journal" following peer reviewed. The version of record is avaliable online at Oxford University web page.	es_ES
dc.title	Sirolimus treatment of left ventricular hypertrophy: who, and when?	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.rights.access	info:eu-repo/semantics/openAccess	es_ES
UDC.journalTitle	European Heart Journal	es_ES
UDC.volume	29	es_ES
UDC.issue	22	es_ES
UDC.startPage	2703	es_ES
UDC.endPage	2704	es_ES